Try our Advanced Search for more refined results
RE40,493
Porous paclitaxel matrices and methods of manufacture thereof
- August 19, 2015 Acusphere Fights Celgene's Bid For Atty Fees In Patent Row
- June 17, 2015 Fed. Circ. Backs Celgene Win In Teva Cancer Drug Patent Suit
- March 18, 2014 Celgene Ducks Teva Unit's Breast-Cancer Drug IP Claims
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
View all the results
Already a subscriber? Click here to login